Rosemary and oregano contain diabetes-fighting compounds
Public Release: 23-Jul-2014 The popular culinary herbs oregano and rosemary are packed with healthful compounds, and now lab tests show they could work in much the same way as prescription…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Public Release: 23-Jul-2014 The popular culinary herbs oregano and rosemary are packed with healthful compounds, and now lab tests show they could work in much the same way as prescription…
20 Apr2012 Researchers discover promising anti-diabetic substance in the amorfrutin class of natural substances It provides the raw material for liquorice candy, calms the stomach and alleviates diseases of the…
Contact: Emma Dickinson edickinson@bmj.com 44-207-383-6529 BMJ-British Medical Journal Joint BMJ/Channel 4 Dispatches investigation The BMJ and Channel 4 Dispatches investigated and found that evidence suggesting potential harm from the drugs…
Contact: Stephanie Desmon sdesmon1@jhmi.edu 410-955-8665 Johns Hopkins Medicine People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms…
Public release date: 30-Apr-2009 - A drug widely used to treat Type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade…
Public release date: 28-Aug-2008 WINSTON-SALEM, N.C. –A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in…
Public release date: 28-May-2008 A new study published in the May 2008 (volume 8, issue 25) edition of the journal of Nutrition Research shows Pycnogenol (pic-noj-en-all), an antioxidant plant…
Public release date: 28-Apr-2008 A widely used class of diabetes medications appears to be associated with an increased risk for fractures, according to a report in the April 28 issue…
Public release date: 11-Dec-2007 Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and…
Public release date: 17-Jul-2007 This Cochrane Systematic Review analysed data from 18 trials that involved a total of 8432 people and found no evidence that rosiglitazone led to better patient…
You must be logged in to post a comment.